These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27797781)

  • 21. Concentration-response evaluation of ToxCast compounds for multivariate activity patterns of neural network function.
    Kosnik MB; Strickland JD; Marvel SW; Wallis DJ; Wallace K; Richard AM; Reif DM; Shafer TJ
    Arch Toxicol; 2020 Feb; 94(2):469-484. PubMed ID: 31822930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zebrafish as a genetic model in pre-clinical drug testing and screening.
    Gibert Y; Trengove MC; Ward AC
    Curr Med Chem; 2013; 20(19):2458-66. PubMed ID: 23521675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designing Drug-Response Experiments and Quantifying their Results.
    Hafner M; Niepel M; Subramanian K; Sorger PK
    Curr Protoc Chem Biol; 2017 Jun; 9(2):96-116. PubMed ID: 28628201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput metabolism-induced toxicity assays demonstrated on a 384-pillar plate.
    Yu KN; Kang SY; Hong S; Lee MY
    Arch Toxicol; 2018 Aug; 92(8):2501-2516. PubMed ID: 29974144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tox21 Enricher: Web-based Chemical/Biological Functional Annotation Analysis Tool Based on Tox21 Toxicity Screening Platform.
    Hur J; Danes L; Hsieh JH; McGregor B; Krout D; Auerbach S
    Mol Inform; 2018 May; 37(5):e1700129. PubMed ID: 29377626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment.
    Wetmore BA
    Toxicology; 2015 Jun; 332():94-101. PubMed ID: 24907440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A versatile, automated and high-throughput drug screening platform for zebrafish embryos.
    Lubin A; Otterstrom J; Hoade Y; Bjedov I; Stead E; Whelan M; Gestri G; Paran Y; Payne E
    Biol Open; 2021 Sep; 10(9):. PubMed ID: 34472582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies.
    Donato MT; Gómez-Lechón MJ; Tolosa L
    Expert Opin Drug Discov; 2017 Feb; 12(2):201-211. PubMed ID: 27936962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
    Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
    Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Silico Study of In Vitro GPCR Assays by QSAR Modeling.
    Mansouri K; Judson RS
    Methods Mol Biol; 2016; 1425():361-81. PubMed ID: 27311474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated in vitro-in silico screening strategy for the discovery of antibacterial compounds.
    Nybond S; Ghemtio L; Nawrot DA; Karp M; Xhaard H; Tammela P
    Assay Drug Dev Technol; 2015; 13(1):25-33. PubMed ID: 25710544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High throughput toxicity screening and intracellular detection of nanomaterials.
    Collins AR; Annangi B; Rubio L; Marcos R; Dorn M; Merker C; Estrela-Lopis I; Cimpan MR; Ibrahim M; Cimpan E; Ostermann M; Sauter A; Yamani NE; Shaposhnikov S; Chevillard S; Paget V; Grall R; Delic J; de-Cerio FG; Suarez-Merino B; Fessard V; Hogeveen KN; Fjellsbø LM; Pran ER; Brzicova T; Topinka J; Silva MJ; Leite PE; Ribeiro AR; Granjeiro JM; Grafström R; Prina-Mello A; Dusinska M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27273980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational in Vitro Toxicology Uncovers Chemical Structures Impairing Mitochondrial Membrane Potential.
    Dreier DA; Denslow ND; Martyniuk CJ
    J Chem Inf Model; 2019 Feb; 59(2):702-712. PubMed ID: 30645939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accurate risk-based chemical screening relies on robust exposure estimates.
    Rudel R; Perovich L
    Toxicol Sci; 2012 Jul; 128(1):295-6; author reply 297-9. PubMed ID: 22523230
    [No Abstract]   [Full Text] [Related]  

  • 35. Design and Implementation of High-Throughput Screening Assays.
    Powell DJ; Hertzberg RP; Macarrόn R
    Methods Mol Biol; 2016; 1439():1-32. PubMed ID: 27316985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ensembler: Enabling High-Throughput Molecular Simulations at the Superfamily Scale.
    Parton DL; Grinaway PB; Hanson SM; Beauchamp KA; Chodera JD
    PLoS Comput Biol; 2016 Jun; 12(6):e1004728. PubMed ID: 27337644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DiSCuS: an open platform for (not only) virtual screening results management.
    Wójcikowski M; Zielenkiewicz P; Siedlecki P
    J Chem Inf Model; 2014 Jan; 54(1):347-54. PubMed ID: 24364790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Throughput Screening for Drug Combinations.
    Shinn P; Chen L; Ferrer M; Itkin Z; Klumpp-Thomas C; McKnight C; Michael S; Mierzwa T; Thomas C; Wilson K; Guha R
    Methods Mol Biol; 2019; 1939():11-35. PubMed ID: 30848454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leveraging high content screening for in vitro cytotoxicity assessment.
    Haskins JR
    Drug Discov Today; 2005; Suppl():1. PubMed ID: 23570159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.